Hana Golding is the Chief of the Laboratory of Retroviruses at the Division of Viral Products, Center for Biologics Evaluation and Research (CBER), United States Food and Drug Administration (FDA), USA. She has received her PhD degree from Oregon Health Sciences University followed by Postdoctoral training at the Experimental Immunology Branch, NCI, NIH. She also is a Co-Manager of the Influenza Research Program in the Division of Viral Products, CBER, FDA. She has authored more than 150 research papers and book chapters on immunology, virology and infectious diseases. Her research areas include HIV, influenza, RSV, smallpox and novel adjuvants (safety and mode of action). Hana Golding is the Chief of the Laboratory of Retroviruses at the Division of Viral Products, Center for Biologics Evaluation and Research (CBER), United States Food and Drug Administration (FDA), USA. She has received her PhD degree from Oregon Health Sciences University followed by Postdoctoral training at the Experimental Immunology Branch, NCI, NIH. She also is a Co-Manager of the Influenza Research Program in the Division of Viral Products, CBER, FDA. She has authored more than 150 research papers and book chapters on immunology, virology and infectious diseases. Her research areas include HIV, influenza, RSV, smallpox and novel adjuvants (safety and mode of action).

Vaccines & Vaccination, Veterinary and Animal Sciences